PRF1 and non-Hodgkin lymphoma: However, total ILC in the PB of NHL patients showed a slight but significant decrease in PD-1 and CD62L expression and a concomitant increase in activation/functional markers such as CD69, granzyme B, and perforin, suggesting a potential involvement of ILC in a direct antitumor effect [24].